[Significance of cytokines for bone loss--are there possible interventions?].
Scharla
S H
SH
Klinikum Berchtesgadener Land (Abteilung Innere Medizin) 83471 Schönau am Königssee, Germany.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D015519:Bone Density / Q000187:drug effects*; D016207:Cytokines / Q000037:antagonists & inhibitors / Q000502:physiology*; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D006887:Hydroxycholecalciferols / Q000627:therapeutic use; D010024:Osteoporosis / Q000139:chemically induced* / Q000276:immunology / Q000517:prevention & control; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D016207:Cytokines; D005938:Glucocorticoids; D006887:Hydroxycholecalciferols; C008088:alfacalcidol